Results 221 to 230 of about 2,983,362 (305)

Agonism of the glutamate receptor GluK2 suppresses dermal mast cell activation and cutaneous inflammation. [PDF]

open access: yesSci Transl Med
Zhang YR   +10 more
europepmc   +1 more source

Ranking of antiseizure medications in a panel of focal seizure models predicts their comparative efficacy in clinical add‐on trials in drug‐resistant focal epilepsy

open access: yesEpilepsia, EarlyView.
Abstract Objective Most antiseizure medications (ASMs) have been discovered by testing in animal models, which are generally thought to predict antiseizure activity in patients. However, it is not known whether any of these models (or a combination of models) can predict whether a novel ASM exhibits higher clinical efficacy in focal drug‐resistant ...
Wolfgang Löscher, Pavel Klein
wiley   +1 more source

A consensus roadmap for post‐traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials

open access: yesEpilepsia, EarlyView.
Abstract Understanding the mechanisms underlying post‐traumatic epilepsy (PTE) following traumatic brain injury (TBI), and developing strategies to prevent or modify its progression, has been the focus of large collaborative efforts within the epilepsy and TBI research communities for over a decade.
Elisa R. Zanier   +82 more
wiley   +1 more source

The glutamate receptor antagonist ifenprodil inhibits hepatitis E virus infection. [PDF]

open access: yesAntimicrob Agents Chemother
Klöhn M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy